Arbutus Biopharma Corporation (LON:0SGC)
London flag London · Delayed Price · Currency is GBP · Price in USD
3.319
+0.010 (0.30%)
At close: Jan 31, 2025

Arbutus Biopharma Market Cap

Arbutus Biopharma has a market cap or net worth of 512.65 million as of February 21, 2025. Its market cap has increased by 55.78% in one year.

Market Cap
512.65M
Enterprise Value
414.56M
Revenue
5.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.32

Market Cap Chart

Since November 15, 2010, Arbutus Biopharma's market cap has increased from 45.31M to 512.65M, an increase of 1,031.34%. That is a compound annual growth rate of 18.52%.

History

DateMarket Cap% Change
Feb 21, 2025512.65M3.58%
Dec 31, 2024494.95M50.38%
Dec 29, 2023329.14M8.78%
Dec 30, 2022302.57M-22.14%
Dec 31, 2021388.61M76.02%
Dec 31, 2020220.78M69.34%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
AstraZeneca 181.54B
Shell 161.28B
HSBC Holdings 157.51B
Unilever 110.61B
Rio Tinto Group 86.77B
RELX PLC 72.31B
BP p.l.c. 70.06B
British American Tobacco p.l.c. 65.18B
Market Cap Rankings